Skip to main content

Day: March 7, 2025

Constellation Software Inc. Announces Results for the Fourth Quarter and Year Ended December 31, 2024 and Declares Quarterly Dividend

TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the fourth quarter and year ended December 31, 2024 and declared a $1.00 per share dividend payable on April 15, 2025 to all common shareholders of record at close of business on March 28, 2025. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated. The following press release should be read in conjunction with the Company’s annual Consolidated Financial Statements, prepared in accordance with IFRS Accounting Standards (“IFRS”) and our annual Management’s Discussion and Analysis for the year ended December 31,...

Continue reading

UNITY Biotechnology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Business Updates

SAN FRANCISCO, March 07, 2025 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt, or reverse diseases of aging, today reported financial results for the fourth quarter and full year ended December 31, 2024. “We expect to receive 24-week topline data from our Phase 2b ASPIRE study in diabetic macular edema (DME) in this quarter,” said Anirvan Ghosh, Ph.D., chief executive officer of UNITY. “DME remains a significant unmet need, and we believe UBX1325 (foselutoclax) has the potential to provide a differentiated treatment option for patients who continue to experience vision loss despite current standard-of-care therapies. With its novel mechanism of action and durable therapeutic profile, UBX1325 could offer meaningful advantages over existing anti-VEGF...

Continue reading

Blueberries Medical Announces C$1 Million Non-Brokered Private Placement

TORONTO, March 07, 2025 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce a non-brokered private placement consisting of the sale of 96,064,935 common shares (“Common Shares”) at a price of C$0.011 per Common Share for aggregate gross proceeds of approximately C$1.05 million (or approximately US$740,000) (the “Offering”). The net proceeds from the sale of the Common Shares are expected to fund and expand operations, for general corporate and working capital purposes. The Offering is expected to close on or about March 25, 2024. It is expected that the Offering will be led by Terraflos Inc. (“Terraflos”), a cannabis company with operations throughout...

Continue reading

S&P Global Ratings affirms Iceland at ‘A+/A-1’, Outlook Stable

S&P Global Ratings has affirmed ‘A+/A-1’ long- and short-term foreign and local currency sovereign credit ratings on Iceland. The outlook is stable. S&P´s ratings on Iceland reflect the country’s very high GDP per capita and strong growth track record, which has been higher than most sovereigns S&P rates in Western Europe, as well as Iceland’s robust institutional framework and sound economic and fiscal policies. The ratings remain constrained by the volatile nature of Iceland’s small, open economy, which, in S&P’s view, is vulnerable to natural events, including volcanic activity, as well as adverse external developments outside of its control, such as geopolitical risks, trade and tariff tensions, and fluctuating terms-of-trade. The small size of Iceland’s economy also somewhat limits...

Continue reading

Pennant Group to Participate in the 2025 Oppenheimer Annual Healthcare Conference

EAGLE, Idaho, March 07, 2025 (GLOBE NEWSWIRE) — The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it will participate in the upcoming 2025 Oppenheimer Co. Annual Healthcare MedTech & Services Conference on March 18, 2025. Brent Guerisoli, Chief Executive Officer, Lynette Walbom, Chief Financial Officer, and Kirk Cheney, Executive Vice President, will participate in a fireside chat on March 18, 2025 at 10:00 a.m. Eastern Time. A live webcast of the event will be accessible at the following address: investor.pennantgroup.com/events-and-presentations. About Pennant: The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 131 home health and hospice...

Continue reading

Canoe EIT Income Fund Announces March 2025 Monthly Distribution

CALGARY, Alberta, March 07, 2025 (GLOBE NEWSWIRE) — Canoe EIT Income Fund (the “Fund”) (TSX – EIT.UN) announces the March 2025 monthly distribution of $0.10 per unit. Unitholders of record on March 21, 2025, will receive distributions payable on April 15, 2025. About Canoe EIT Income FundCanoe EIT Income Fund is one of Canada’s largest closed-end investment funds, designed to maximize monthly distributions and capital appreciation by investing in a broadly diversified portfolio of high quality securities. The Fund is listed on the TSX under the symbol EIT.UN, and is actively managed by Robert Taylor, Senior Vice President and Chief Investment Officer, Canoe Financial. About Canoe Financial Canoe Financial is one of Canada’s fastest growing independent mutual fund companies managing over $19,5 billion in assets across a diversified...

Continue reading

Wah Fu Education Group Ltd. Announces Financial Results for the First Half of Fiscal Year 2025

BEIJING, March 07, 2025 (GLOBE NEWSWIRE) — Wah Fu Education Group Limited (“Wah Fu” or the “Company”) (NASDAQ:WAFU), a provider of online education and exam preparation services, as well as related training materials and technology solutions for both institutions and individuals, today announced its unaudited financial results for the six months ended September 30, 2024. Financial Highlights for the Six Months Ended September 30, 2024    For the Six Months EndedSeptember 30,  ($’000, except per share data)   2024     2023     % Change  Revenue   $ 2,799     $ 3,648       (23.3 )%Gross profit   $ 1,572     $ 2,063       (23.8 )%Gross margin     56.1 %     56.6 %     (0.5 )pp(Loss) income from operations   $ (571 )   $ 273       (309.5 )%Operating (loss) profit margin     (20.4 )%     7.5 %     (27.9 )ppNet...

Continue reading

AMREP Reports Third Quarter Fiscal 2025 Results

HAVERTOWN, Pa., March 07, 2025 (GLOBE NEWSWIRE) — AMREP Corporation (NYSE:AXR) today reported net income of $717,000, or $0.13 per diluted share, for its 2025 fiscal third quarter ended January 31, 2025 compared to net income of $92,000, or $0.02 per diluted share, for the same period of the prior year. For the first nine months of 2025, AMREP had net income of $8,823,000, or $1.64 per diluted share, compared to net income of $2,546,000, or $0.48 per diluted share, for the same period of 2024. Revenues were $7,520,000 and $38,516,000 for the third quarter and first nine months of 2025 and $12,689,000 and $31,833,000 for the third quarter and first nine months of 2024. More information about the Company’s financial performance may be found in AMREP Corporation’s financial statements on Form 10-Q which have today been filed with...

Continue reading

Meritage Announces 2024 Full-Year Results; 2025 Outlook: Accelerating Earnings Growth

GRAND RAPIDS, Mich., March 07, 2025 (GLOBE NEWSWIRE) — Meritage Hospitality Group Inc. (OTCQX: MHGU), one of the nation’s premier franchise restaurant operators, today reported financial results for the fourth quarter and fiscal year ended December 29, 2024. 2024 Fourth Quarter Highlights:Sales increased 0.5% to $168.7 million compared to sales of $167.9 million for the same period last year. Earnings (Loss) from Operations were $(0.1) million compared to $4.8 million for the same period last year.        Net Income increased 227% to $5.2 million compared to $1.6 million for the same period last year. Consolidated EBITDA (a non-GAAP measure) increased 40.8% to $13.7 million compared to $9.7 million for the same period last year.2024 Full-Year Highlights:Sales were $668.8 million compared to $672.5 million last year. Earnings...

Continue reading

NI Holdings, Inc. Reports Results for Fourth Quarter and Year Ended December 31, 2024

FARGO, N.D., March 07, 2025 (GLOBE NEWSWIRE) — NI Holdings, Inc. (“NI Holdings,” or the “Company,” NASDAQ: NODK) announced today results for the year ended December 31, 2024. Summary of Year-End 2024 Results(All comparisons vs. continuing operations for the year-end 2023, unless noted otherwise)Strong fourth quarter net income of $9.9 million, with 16.2% return on average equity. Fourth quarter combined ratio of 80.0%, up 1.3 pts compared to the prior year quarter, reflecting excellent underwriting results in our Private Passenger Auto and Home and Farm segments, partially offset by unfavorable prior year reserve development and further current year reserve strengthening in Non-Standard Auto. Combined ratio of 100.7% for full year 2024 versus 97.0% for the prior year, driven by unfavorable prior year reserve development in Non-Standard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.